Update on VIP Pick BCRX: Bucks the Market Trend after Significant Developments

StoryTrading contributor Zak, provides an update on VIP Pick BioCryst Pharmaceuticals (BCRX) after a series of significant catalysts including raised guidance for Orladeyo and $300M in non-dilutive financing.

BCRX is up over 250% since it was first introduced to the StoryTrading community as a VIP Pick. Find out what comes next!

----------------
Check out StoryTrading here: https://www.storytrading.com/​​
You can learn more about BCRX here: https://www.biocryst.com/

Disclaimer:
StoryTrading is not a registered investment advisor. Anything said in the video is for informational, educational, and entertainment purposes only and should not be considered as investment advice or a recommendation to invest in any particular security, strategy, or investment product. Investing in securities involves significant risk of loss. Past performance is no indication or guarantee of future results and the value of any investment you make may go up or down.

Visit our website to view our full disclaimer. https://www.storytrading.com/disclaimer/